IP Library Granted Patent US 7,329,236
Granted Patent B2
US 7,329,236 · App. 11/221,679 · Granted Feb 12, 2008

Intra-aortic renal drug delivery catheter

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,329,236
App. No.
11/221,679
Granted
Feb 12, 2008
Kind
B2
Abstract

A catheter for delivering a therapeutic or diagnostic agent to a branch blond vessel of a major blood vessel comprises an elongated shaft having at least one lumen in fluid communication with an agent delivery port in a distal section of the shaft, an expandable tubular member on the distal section of the shaft, and a radially expandable member on the tubular member. The tubular member is configured to extend within the blood vessel up-stream and down-stream of a branch vessel, and has an interior passageway which is radially expandable within the blood vessel to separate blood flow through the blood vessel into an outer blood flow stream exterior to the tubular member and an inner blood flow stream within the interior passageway of the tubular member.

Claims (41)

1. A system for enhancing renal function in a patient, comprising:

a delivery catheter with a proximal end portion and a distal end portion with a fluid delivery port;

a flow diverter located along the distal end portion, the flow diverter comprising a tubular member that when in an expanded configuration provides an interior passageway therein, the interior passageway having a proximal opening and a distal opening, such that the proximal opening of the interior passageway is disposed proximal to the fluid delivery port and the distal opening of the interior passageway is disposed distal to the fluid delivery port;

a pull wire having a distal end that is coupled with the tubular member; and

a source of fluid agent;

wherein the tubular member is configured to expand from a low profile configuration to an expanded configuration when the pull wire is retracted proximally, such that in the expanded configuration the tubular member provides an interior passageway that extends between a proximal opening of the tubular member and a distal opening of the tubular member;

wherein the delivery catheter is adapted to couple to the source of fluid agent;

wherein the delivery catheter is adapted to position the distal end portion at a location within an abdominal aorta associated with a plurality of renal artery ostia having unique respective positions along the abdominal aorta wall;

wherein when the tubular member is in the expanded configuration so as to provide the interior passageway therein, the flow diverter at the location is adapted to divert a portion of aortic blood flow along a diverted flow path external to the tubular member and substantially only into the plurality of renal arteries via their respective ostia and to allow a second portion of aortic blood flow from the distal opening of the interior passageway downstream across the plurality of renal artery ostia to the proximal opening of the interior passageway;

wherein the fluid delivery port is positioned relative to the flow diverter so as to inject a volume of the fluid agent from the source into the diverted flow path; and

wherein the fluid agent is adapted to enhance renal function.

2. The system of claim 1 , wherein the fluid agent comprises a vasoactive agent.

3. The system of claim 1 , wherein the fluid agent comprises a member selected from the group consisting of Papaverine, a Calcium-channel blocker, Nifedipine, Verapamil, Fenoldapam, and a dopamine DA1 agonist.

4. The system of claim 1 , wherein the tubular member comprises a conical shape or a frustroconical shape.

5. The system of claim 1 , wherein the tubular member comprises an inflatable member.

6. The system of claim 1 , wherein the tubular member comprises a spring force that urges the tubular body to elongate and reduce in diameter.

7. The system of claim 1 , wherein the tubular member comprises braided filaments.

8. The system of claim 1 , wherein the tubular member comprises an agent delivery opening that is adjacent to the fluid delivery port of the delivery catheter.

9. The system of claim 1 , wherein the fluid delivery port is proximal to a distal end of the tubular member.

10. A system for enhancing renal function in a patient, comprising:

a delivery catheter with a proximal end portion and a distal end portion with a fluid delivery port;

a flow diverter located along the distal end portion, the flow diverter comprising a tubular member that when in an expanded configuration provides an interior passageway therein, the interior passageway having a proximal opening and a distal opening, such that the proximal opening of the interior passageway is disposed proximal to the fluid delivery port and the distal opening of the interior passageway is disposed distal to the fluid delivery port, the tubular member comprising a self-expanding frame;

a source of fluid agent; and

a restraining member configured to apply a compressive force to the self-expanding frame so as to hold the frame in a low profile configuration;

wherein the tubular member is configured to expand from the low profile configuration to an expanded configuration when the restraining member is removed, such that in the expanded configuration the tubular member provides an interior passageway that extends between a proximal opening of the tubular member and a distal opening of the tubular member;

wherein the delivery catheter is adapted to couple to the source of fluid agent;

wherein the delivery catheter is adapted to position the distal end portion at a location within an abdominal aorta associated with a plurality of renal artery ostia having unique respective positions along the abdominal aorta wall;

wherein when the tubular member is in the expanded configuration so as to provide the interior passageway therein, the flow diverter at the location is adapted to divert a portion of aortic blood flow along a diverted flow path external to the tubular member and substantially only into the plurality of renal arteries via their respective ostia and to allow a second portion of aortic blood flow from the distal opening of the interior passageway downstream across the plurality of renal artery ostia to the proximal opening of the interior passageway;

wherein the fluid delivery port is positioned relative to the flow diverter so as to inject a volume of the fluid agent from the source into the diverted flow path; and

wherein the fluid agent is adapted to enhance renal function.

11. The system of claim 10 , wherein the frame comprises a plurality of longitudinally extending filaments joined together at proximal and distal ends thereof.

12. The system of claim 10 , comprising a sheath coupled with the self-expanding frame.

13. The system of claim 10 , wherein the fluid agent comprises a vasoactive agent.

14. The system of claim 10 , wherein the fluid agent comprises a member selected from the group consisting of Papaverine, a Calcium-channel blocker, Nifedipine, Verapamil, Fenoldapam, and a dopamine DA1 agonist.

15. The system of claim 10 , wherein the tubular member comprises a conical shape or a frustroconical shape.

16. The system of claim 10 , wherein the tubular member comprises an inflatable member.

17. The system of claim 10 , wherein the tubular member comprises a spring force that urges the tubular body to elongate and reduce in diameter.

18. The system of claim 10 , wherein the tubular member comprises braided filaments.

19. The system of claim 10 , wherein the tubular member comprises an agent delivery opening.

20. The system of claim 10 , wherein the tubular member comprises an agent delivery opening that is adjacent to the fluid delivery port of the delivery catheter.

21. The system of claim 10 , wherein the fluid delivery port is proximal to a distal end of the tubular member.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 040688/0540 →
SECURITY INTEREST Recorded Nov 8, 2016
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 040613/0049 →
SECURITY AGREEMENT Recorded Sep 30, 2013
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031315/0720 →